Switch to:
More From Other Websites
Amgen's PCSK9 Inhibitor, Repatha, Approved in the U.S. Aug 28 2015
Time to Buy Amgen After Newly Approved Drug? Aug 28 2015
Amgen's Repatha OK'd With Similar Label To Praluent Aug 27 2015
Cholesterol drug wars Aug 27 2015
Cholesterol drug wars: Amgen Aug 27 2015
MannKind And Afrezza: Can The Drug Cure The Company? Aug 26 2015
Dividend cuts for big oil? Aug 20 2015
Cholesterol war heats up Aug 20 2015
Relypsa Enters Two-Year Detailing Agreement With Sanofi in the United States Aug 18 2015
Wait, There are Still Cheap Pharma Stocks? Aug 18 2015
Research and Markets: Investigation Report on China's Polyene Phosphatidyl Choline Market 2010-2019 Aug 17 2015
John Buckingham Buys 10 New Stakes in Second Quarter Aug 14 2015
VCEL: Solid Q2 Financial Results. Expect Continued Revenue Growth in 2H 2015 Aug 14 2015
Payers Set To Play Hardball On PCSK9 Pricing: RBC Aug 13 2015
The Chemical Works of Gedeon Richter Plc Earnings Q2*, 2015 Aug 13 2015
Immune Design's Q2 Loss Narrows Y/Y, Focus on Pipeline Aug 13 2015
Make Room for Exelixis in Your Portfolio Aug 12 2015
Takeda Pharmaceutical Co., Ltd. Earnings Q2*, 2015 Aug 12 2015


Add Notes, Comments

If you want to ask a question or report a bug, please create a support ticket.

User Comments

No comment yet


Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)

GuruFocus Premium Plus Membership

FEEDBACK